Replies to post #103027 on Bioelectronics Corp (BIEL)

[Simpsonly]

I will take JNJ or GSK stock 8 days a week! No question, BIEL is a potential target of interest for every player in the pain space. USPTO patents, miniaturized pain management device, FDA USA OTC cleared, with FDA clearance certifying it is both efficacious and safe? Combining IP and clearance - only such device on earth!

Only a question now of when someone blinks. If I am BIEL's CEO, I can say nothing, by law! But to think it is not of interest to others is an absurd lack of sophistication, since every pharma executive in the world wants to protect and grow market share. This is about nothing else. And, when it is appropriate for us to know, it will happen, not if, but when . . . .

[srinsocal]

I am sure there are many things for BIEL to consider when deciding on a path forward.

Two issues come to mind that have to factor into AW's decision making process regarding how to handle the fantastic opportunity that FDA OTC Clearance presents.

He is in his mid seventies. Does he want to spend his remaining years running BIEL or checking off items on his Bucket List?

The recent passing of his brother is a harsh reminder that we all have a limited time in this world.